期刊文献+

烟草致癌原NNK诱发大鼠肺癌前病变的实验研究 被引量:5

Induction of pulmonary precancerous lesions by tobacco-specific NNK in Wistar rats
暂未订购
导出
摘要 背景与目的4(甲基亚硝胺基)1(3吡啶)1丁酮[4(methylnitrosamino)1(3pyridyl)1butanone,NNK]是烟草中主要的致癌原。为了研究NNK的致癌机制,寻找针对NNK所致肺癌的有效的化学防护措施,建立以NNK诱发的动物模型是非常有效的研究手段。本研究的目的是观察一次性支气管灌注NNK致Wistar大鼠的肺组织的病理变化,并探讨病变发生机制。方法实验组Wistar大鼠15只,左肺叶下部支气管内灌注含NNK50mg/kg(高剂量组,5只)或25mg/kg(低剂量组,10只)的碘油溶液0.1mL,X线影像学监测病变进展。另15只Wistar大鼠灌注不含NNK的碘油,作为对照。HE染色观察大鼠肺组织病理变化,免疫组化SP法检测AE1/AE3、PCNA、p53蛋白表达。结果灌注碘油后数字减影血管造影(digitalsubtractionangiography,DSA)显示碘油分布于大鼠左肺叶下部,第107天DSA显示左肺叶下部的碘油影像消失。实验组67%(10/15)的大鼠(高剂量组4只,低剂量组6只)左肺下部见绿豆大小的结节状实变病灶。HE染色示实验组100%(15/15)的大鼠左肺组织出现局灶性肺泡细胞的不典型增生,肺泡间隔增宽,肺泡腔狭窄;67%(10/15)的大鼠左肺有腺上皮的高度不典型增生,部分增生的细胞构成小腺体,偶见异型增生腺体向支气管壁的肌层侵犯。免疫组化染色显示实验组不典型增生细胞的角蛋白AE1/AE3阳性。PCNA在对照组和NNK低、高剂量组的阳性表达率分别为13%(2/15)、90%(9/10)、100%(5/5),后两者与对照组的差异均有统计学意义(P=0.000,P=0.001),而低、高剂量组之间差异无统计学意义(P=1.000)。p53蛋白在对照组肺组织中表达为阴性,在NNK低、高剂量组中表达率分别为50%(5/10)和60%(3/5),均较对照组明显升高(P=0.005,P=0.009),而低、高剂量组之间差异无统计学意义(P=1.000)。结论对Wistar大鼠的左肺叶支气管灌注含NNK的碘油溶液可在局部诱发肺泡细胞和腺上皮的不典型增生。该模型可用于烟草致肺癌的实验研究。 Background and objective Tobacco-specific 4-(methylnitrosamino)-1-(3-pyriclyl)-1-butanone (NNK) is the most important carcinogen in cigarette. Models induced by NNK are widely used in investigations about the mechanisms of pulmonary neoplasia ancl chemoprevention studies. The aim of this study is to explore the pulmonary precancerous lesions induced by NNK ancl its possible mechanisms. Methods Fifteen Wistar rats were divided into two trial groups, in which the high-dose group was instilled with iodized oil including 10 mg (50 mg/kg) NNK into the left lower lobar bronchus, and the low-dose group received 5 mg (25 mg/kg) NNK. Another 15 Wistar rats were instilled only with iodized oil as control group. All rats were examined immediately after instillation and followed up periodically by pulmogram. The pulmonary tissues of rats were pathologically examined, and the expression of AE1/AE3, PCNA and p53 was detected by immunohistochemieal method. Results The pulmograms showed that the iodized oil localized at the bottom of left lobe and disappeared 107 days later. In trial group, 10 of 15 rats (67%) had nodus at the bottom of left lobe. All of rats in trial group (15/15) displayed atypical hyperplasia in alveolar region, showing single or multiple layers of proliferative epithelial cells along intact alveolar septa with irregular and non-discrete margins of lesion, but continuous alveolar spaces were not obliterated by proliferative epithelial cells. Ten of 15 rats in trial group showed severe atypical hyperplasia of glandular epithelium with occasional infiltrating to mucular layer.All of those atypical hyperplasia sells showed positive AE1/AE3 expression.The positive rate of PCNA was 90% (9/10) and 100%(5/5) in low-dose group and high-dose group respectively,which was significantly higher than that in control group(13%,2/15)(P=0.000,P=0.001).The positive rate of p53 expression was 50%(5/10) and 60%(3/5) in low-dose group and high-dose group respectively,which was significantly higher than that in control group(0)(p=0.005,P=0.009),However,there was no remarkable difference in PCNA and p53 expression between low-dose group and high-dose group(P〉0.05).Conclusion Transbronchial instillation of iodized oil including tobacco-specific NNK can induce pulmonary lesions as atypical hyperplasia of alveolar cell and glandular epithelium in Wistar rats.This model can be used in experimental studies about tobacco-related lung cancer.
出处 《中国肺癌杂志》 CAS 2006年第2期152-156,共5页 Chinese Journal of Lung Cancer
关键词 NNK 肺肿瘤 WISTAR大鼠 P53蛋白 NNK Lung neoplasms Wistar rat p53 protein
  • 相关文献

参考文献12

  • 1Wynder EL, Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res, 1994,54 (20):5284-5295.
  • 2Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 1988,9(6) : 875-884.
  • 3El-Bayoumy .K, latropoulos M, Amin S, et al. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-( methylnitrosamino)-4-( 3-pyridyl )-1-butanone: the impact of a high-fat diet. Cancer Res, 1999,59(7) :1400 1403.
  • 4Hecht SS, Morse MA, Amin S, et al. Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl) 1-butanone and the effect of diet. Carcinogenesis, 1989,10(10) : 1901-1904.
  • 5Castonguay A, Pepin P, Stoner GD. Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Exp Lung Res, 1991,17(2) : 485-499.
  • 6Castonguay A, Rioux N. Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis,1997,18(3) : 491-496.
  • 7Tian HS, Liu MQ, Gao WQ, et al. Induction of lung carcinoma by intralobar bronchial instillation of iodized oil in rats. Chin Med J(Engl),1984,97(1):36-40.
  • 8Chen YK, Huse SS, Lin LM. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas, Int J Exp Pathol,2004,85(2) :97-104.
  • 9Belinsky SA,Foley JF, White CM, et al.Dose-response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res,1990,50(12):3772-3780.
  • 10Belinsky SA, Devereux TR, White CM, et al. Role of Clara cellsand type Ⅱ cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine. Exp Lung Res,1991,17(2) : 263-278.

同被引文献57

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部